PATENT CLAIM ANALYSIS

Application Number: 15761725
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "017800"]

Abstract:
The present invention relates to an agent which inhibits Kallikrein-8 for use in the treatment or prevention of Alzheimer's disease and/or its precursor stages, as well as to methods, kits and uses relating thereto, including diagnostic tools.

Claim (Index 2):
The agent for use according to  claim 1 , wherein the agent (1) specifically binds to Kallikrein-8 and inhibits the proteolytic activity of Kallikrein-8, or (2) is capable of reducing the level of Kallikrein-8 in the brain of a patient.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.10526
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12157664', '13393220', '14324289', '13701758', '11185907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7778324578901719
- 35 USC 102 Novelty (BERT): 0.5250555734646996
- Combined Prediction Score: 0.7525547694476247
- Mean Citation Score: 308.592442
- Max Citation Score: 328.3323
- Similarity Product: 228.851320622009

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test